InhaleRX Gains Approval for Clinical Trial to Test Non-opioid Therapy for Cancer Pain

The Market HeraldNov 14, 2024 19:17 ET

InhaleRx Procures $38.5m in Funding From Clendon Biotech to Progress Inhaled Therapies

Small CapsOct 17, 2024 23:01 ET

InhaleRx Surges 77% After Securing Nearly AU$39 Million for Clinical Trials; Shares Surge 59%

MT NewswiresOct 17, 2024 22:26 ET

InhaleRX Snags $38.5M in Funding From VC Biotech Funder Clendon

The Market HeraldOct 17, 2024 20:47 ET

InhaleRx Ltd: Half Yearly Report and Accounts

Aug 30, 2024 04:37 ET · Announcements

InhaleRx Ltd Hosts Investor Webinar on Future Strategies

TipRanksJul 25, 2024 00:17 ET